Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Orforglipron

A Drug-Drug Interaction Study of Orforglipron (LY3502970) in Healthy Overweight and Obese Participants

Eli Lilly · Phase 1 · Completed · Enrollment 50

NCT06186622

ArmPopulationDoseWeeksEstimandWeight change
Cohort 1: Oral Drug Dosing With or Without Orforglipron Co-AdministrationObesity or overweightn/r24n/rn/r
Cohort 2: Oral Drug Dosing With or Without Orforglipron Co-AdministrationObesity or overweightn/r24n/rn/r